MERLIN introduced at ISCT 2014

Project Partner Orbsen Therapeutics presented at the ISCT Paris Conference on April 22nd 2014, in a session entitled “EU funded projects in Cell Therapy”.

Read more

Coverage in The Irish Times

The Irish Times covered the MERLIN Project on April 22nd, 2014, in an article titled “Orbsen Therapeutics to take part in €6m liver disease clinical trial.”

Article Abstract:

Orbsen Therapeutics, a spin-out from NUI Galway’s Regenerative Medicine Institute (Remedi) has announced plans to partner with the University of Birmingham in a €6 million project to fight liver disease.

The stem cell research company, which was founded by Prof Frank Barry and Prof Tom O’Brien in 2006, will collaborate with the university on an EU FP7-funded project known by as Merlin (MEsynchymal stem cells to Reduce Liver INflammation). The project, which is led by Prof Phil Newsome, will advance Orbsen’s proprietary cell therapy to a Phase 2a clinical trial.

Please read the rest of the article here.

MERLIN Kickoff Meeting

MERLIN partners meet in Birmingham, UK, on 10-11 February, 2014 to initiate the project.

Read more

MERLIN Project Website Launched

The MERLIN project website is now launched. This website will support individuals trying to find out more about the project, and will provide both the public and other researchers with information about our plans, hypotheses, work and results.

Read more